Zeposia (ozanimod) — Medica

Initial criteria

• Patient is age ≥ 18 years; AND
• Medication is prescribed by or in consultation with a gastroenterologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months; AND
• When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline (prior to initiating the requested drug) (e.g., improvement in fecal or serum inflammatory markers, endoscopic findings, or reduced corticosteroid dose); OR
• Compared with baseline, patient experienced an improvement in at least one symptom such as decreased pain, fatigue, stool frequency, and/or decreased rectal bleeding

Approval duration

Initial: 6 months; Renewal: 1 year